These are two different kinds of treatment, and "Exion" is not one treatment. Microneedling here means the mechanical kind: a motorised cartridge of fine needles making thousands of tiny channels in the skin, with no energy source at all. Exion is a BTL platform with several applicators - one with needles and radiofrequency, and separate face and body applicators that heat without breaking the skin.
The first question to ask is which Exion applicator you are being sold. Only one of them has needles: the Exion Fractional RF applicator, documented with 36 needles in a 6 by 6 grid, adjustable from 0.5 to 4.0 mm, running at 1 MHz. The non-invasive Face and Body applicators do not penetrate the skin. BTL describes them as combining radiofrequency with targeted ultrasound; the cleared wording covers only heating tissue for temporary pain relief, muscle spasm and local circulation, plus a temporary reduction in the appearance of cellulite for one massage attachment.
The regulatory position runs the opposite way to what most people expect. Mechanical microneedling holds a genuine cosmetic authorisation: SkinPen Precision was granted through a De Novo request in March 2018 to improve the appearance of facial acne scars in adults aged 22 and over, later extended to neck wrinkles in Fitzpatrick skin types II to IV. Exion's needle applicator carries no cosmetic wording at all - depending on which tip is fitted, it is cleared either for electrocoagulation and hemostasis, or for "dermatological procedures requiring fractional treatment of the skin" (K211639, March 2022).
SkinPen and Dermapen 4 are the two with named US authorisations.
The needle one is the Exion Fractional RF applicator. The brand name Exion does not appear in the FDA 510(k) database; the applicators are registered under BTL's BTL-785 platform.
Channels through the outer skin into the dermis set off the normal wound-healing response - growth factors, fibroblasts, new collagen. No heat is delivered.
Whether the needle applicator runs monopolar - the current travelling through the tissue to a return pad - or bipolar, where it stays between electrodes inside the tip, is not stated in the FDA summary, and nor is whether the needles are insulated.
SkinPen: facial acne scars in adults 22 and over across all Fitzpatrick types, plus neck wrinkles in Fitzpatrick II to IV. Dermapen 4: facial acne scars in Fitzpatrick I to V, with no neck indication.
The non-needle Face and Body applicators are cleared for heating tissue for temporary pain relief, muscle spasm and local circulation, and one massage attachment for a temporary reduction in the appearance of cellulite.
It does not meaningfully tighten lax tissue, and it does not reach or heat fat, so it has no contouring effect.
No published trial names Exion, so what it achieves is inferred from the wider radiofrequency microneedling literature rather than shown for this device.
This is the conventional clinical description, not a figure from the FDA label.
For radiofrequency microneedling generally: redness in essentially everyone and swelling in about 3 in 10 in a 44-patient study, and 3 to 4 days of downtime in a 33-patient study.
Published protocols for radiofrequency microneedling cluster at three sessions, three to eight weeks apart.
BTL markets the fractional applicator as using AI-controlled radiofrequency with real-time impedance monitoring, and markets an ultrasound imaging module on the platform that measures water and collagen in the dermis. Neither of those features appears in the FDA paperwork for the device. They are manufacturer descriptions.
The same distinction applies to the claims people ask about most. Marketing around this platform talks about hydration and about stimulating the skin's own hyaluronic acid. Those are claims, not findings. No published trial names Exion at all - not for hydration, not for hyaluronic acid, not for wrinkles, not for anything. That is not the same as saying the claims are false. It means nobody has demonstrated them in the public record, and a reader is entitled to see the two things kept apart.
What is documented for the needle applicator, from its FDA summary: 36 needles in a 6 by 6 grid, 0.5 to 4.0 mm, 1 MHz.
For mechanical microneedling, the strongest evidence is in acne scars. A review that pooled 24 randomised trials covering 1,546 participants and ranked the treatments against each other found microneedling combined with other treatments outperformed microneedling alone, with microneedling plus a chemical peel ranking best on improvement, satisfaction and efficacy.
For radiofrequency microneedling as a class - not Exion specifically - acne scars are also the best-evidenced use: a systematic review of 16 studies and 481 patients, including 6 randomised trials, concluded it is "likely" effective on its own, and a 2026 split-face trial in which the assessors did not know which side had which treatment found no significant difference from fractional CO2 laser, with shorter redness, pain, swelling and scabbing and fewer episodes of darkened skin afterwards. The heat is also what makes tightening plausible, which is the one thing mechanical needling is not authorised for and does not claim.
Six months is where the measured evidence stops for radiofrequency microneedling. No controlled study has followed anyone longer, and no published trial has compared mechanical microneedling against Exion.
Radiofrequency brings risks that a mechanical needle does not. An analysis of the FDA's postmarket reporting database from 2013 to 2025 found 114 reports containing 224 events across radiofrequency microneedling devices as a group: 56 textural changes, 41 pigment changes, 26 involving fat loss and 14 burns. That database is voluntary and has no denominator, so none of those numbers can be turned into a chance that something happens to you. Set against it, a split-face study in 30 people who completed it measured the fat layer under the chin by ultrasound and found the dermis thickened while the fat layer did not change significantly.
Mechanical microneedling has its own hazard, and it is one both treatments share: what gets applied into freshly made channels. A systematic review of granulomas after microneedling - stubborn inflammatory lumps in the treated skin - collected 13 studies and 15 patients, with motorised pens and topical vitamin C implicated in most cases, and improvement or clearance happened inconsistently across the treatments tried. That is a reason to be cautious about serums applied straight after either procedure.
Radiofrequency also carries a device-specific caution mechanical needling does not: pacemakers, defibrillators and metal implants.
If you get cold sores, say so when you book, not on the day. Antiviral medicine is started in advance, so it has to be prescribed beforehand. There is no published data on cold sore reactivation after radiofrequency microneedling specifically; the precaution is carried over from laser resurfacing, where reactivation is well documented.
If radiofrequency is involved, also disclose a pacemaker or implantable defibrillator, and any metal implant in or near the treatment area. These are labelled contraindications for radiofrequency devices generally, precautionary rather than tested, and your cardiology team is the right source of advice.